Breakthrough Cancer Pain Influences General Activities and Pain Management: A Comparison of Patients with and without Breakthrough Cancer Pain.

BACKGROUND Breakthrough cancer pain (BTcP) is a predictor of interference with general activities and poor pain management. The extent of this influence has not yet been determined. OBJECTIVE This study aimed to investigate the influence of BTcP on general activities, and pain management in patients with controlled background pain. DESIGN Single-center prospective observational study. SETTING/SUBJECTS The study cohort comprised 258 consecutive patients (female, 40.0%; mean age, 64.5 years) who had received opioid medication for cancer pain for over 2 weeks. MEASUREMENTS A recommended diagnostic algorithm was used to quantitate and compare interference with general activities, average background pain intensity over the previous 24 hours (24h-PI), and achievement of personalized pain goals (PPGs) (24h-PI≤PPG) of 119 patients with and 139 patients without BTcP. RESULTS Interference with general activities, 24h-PI, and PPG scores [mean (standard deviation)] in patients with BTcP were 2.8 (2.2), 3.0 (1.7), and 1.8 (1.4), respectively, which are all significantly higher than for those without BTcP [1.3 (2.0), p < 0.01; 1.7 (1.6), p < 0.01; 1.5 (1.3), p = 0.03], respectively. A significantly smaller percentage of patients with BTcP than without BTcP achieved their PPGs (36.1% vs. 67.6%, p < 0.01). CONCLUSIONS BTcP has a negative impact on general activities and pain management. Healthcare providers should recognize that management of BTcP is important in improving general activities and management of cancer pain.

[1]  Y. Matsumoto,et al.  Comparison of Indicators for Achievement of Pain Control With a Personalized Pain Goal in a Comprehensive Cancer Center. , 2017, Journal of pain and symptom management.

[2]  A. Davies,et al.  Observational study of sleep disturbances in advanced cancer , 2017, BMJ Supportive & Palliative Care.

[3]  E. Zecca,et al.  Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS) , 2016, Advances in Therapy.

[4]  M. Hjermstad,et al.  Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer , 2016, BMJ Supportive & Palliative Care.

[5]  A. Caraceni,et al.  Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group , 2016, Supportive Care in Cancer.

[6]  M. Cowie,et al.  Development and validation of the breakthrough pain assessment tool (BAT) in cancer patients. , 2014, Journal of pain and symptom management.

[7]  L. Radbruch,et al.  Breakthrough cancer pain: an observational study of 1000 European oncology patients. , 2013, Journal of pain and symptom management.

[8]  C. Ficorella,et al.  Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies , 2013, Current medical research and opinion.

[9]  F. Fulfaro,et al.  Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients , 2013, Current medical research and opinion.

[10]  E. Bruera,et al.  Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center , 2012, Cancer.

[11]  M. Maltoni,et al.  Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI--Italian questionnaire for intense episodic pain. , 2012, Journal of pain and symptom management.

[12]  C. Benedetti,et al.  Adult Cancer Pain: Clinical Practice Guidelines in Oncology , 2010 .

[13]  S. Kaasa,et al.  Episodic (breakthrough) pain , 2002, Cancer.